VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,096,662 | +72.1% | 1,298,493 | +62.5% | 0.13% | +69.2% |
| Q2 2023 | $26,207,200 | -26.8% | 799,000 | -25.3% | 0.08% | -29.7% |
| Q1 2023 | $35,824,900 | +188.0% | 1,069,400 | +181.9% | 0.11% | +164.3% |
| Q4 2022 | $12,437,247 | +392.8% | 379,300 | +83.8% | 0.04% | +281.8% |
| Q2 2022 | $2,524,000 | -17.8% | 206,400 | -8.8% | 0.01% | -8.3% |
| Q1 2022 | $3,071,000 | – | 226,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |